Please assess the completion status of the following clinical trial:

Trial Title: Prothrombin Complex Concentrate for Anticoagulant Reversal

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Key Inclusion Criteria:~* Subjects on oral anticoagulation requiring rapid reversal due to acute bleeding or emergency surgery~* INR \> 2 at baseline~Key Exclusion Criteria:~* Acute thromboembolic event~* Treatment with any other investigational drug in the last 30 days before study entry~* Less than 2 weeks of stable oral anticoagulation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).